MPC1

Chr 6AR

mitochondrial pyruvate carrier 1

Also known as: BRP44L, CGI-129, MPYCD, SLC54A1

The protein encoded by this gene is part of an MPC1/MPC2 heterodimer that is responsible for transporting pyruvate into mitochondria. The encoded protein is found in the inner mitochondrial membrane. Defects in this gene are a cause of mitochondrial pyruvate carrier deficiency. Several transcript variants, some protein coding and one non-protein coding, have been found for this gene. [provided by RefSeq, Aug 2012]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.191 OMIM phenotype
Clinical SummaryMPC1
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 18 VUS of 66 total submissions
📖
GeneReview available — MPC1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.19LOEUF
pLI 0.038
Z-score 1.28
OE 0.46 (0.211.19)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.07Z-score
OE missense 0.62 (0.480.81)
40 obs / 64.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.46 (0.211.19)
00.351.4
Missense OE?0.62 (0.480.81)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 3 / 6.5Missense obs/exp: 40 / 64.2Syn Z: -0.09

This gene — mechanism propensity

DN
0.85top 10%
GOF
0.73top 25%
LOF
0.2580th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

66 submitted variants in ClinVar

Classification Summary

Pathogenic2
Likely Pathogenic4
VUS18
Likely Benign17
Benign15
2
Pathogenic
4
Likely Pathogenic
18
VUS
17
Likely Benign
15
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
0
0
2
Likely Pathogenic
0
4
0
0
4
VUS
2
15
1
0
18
Likely Benign
0
2
8
7
17
Benign
0
1
13
1
15
Total22422856

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

53 pathogenic / likely-pathogenic (of 60) ClinVar copy-number / structural variants overlap MPC1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MPC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →